Professor Licinio is an internationally recognised translational research leader in major depression, its biology and metabolic outcomes. His h-index is 60, with 18000 citations and publications in leading journals, such as Nature, Science, Cell, PNAS, and Lancet. He is an RANZCP Fellow with AHPRA registration as specialist in psychiatry. He is a member of the Scientific Program Committee, American Psychiatric Association, the Membership Committee, American College of Neuropsychopharmacology, and he is founding (and current) Chief Editor of three Nature Publishing Group journals: Translational Psychiatry (IF=4.36), The Pharmacogenomics Journal (IF=5.5), and Molecular Psychiatry (IF=15.147), ranked number 1 in its field worldwide.